Search for: "SANOFI-AVENTIS V APOTEX"
Results 41 - 60
of 92
Sorted by Relevance
|
Sort by Date
25 Jul 2013, 11:43 am
Lucier was a thalidomide case against GSK, SmithKline Beecham, Sanofi-Aventis, Grunethal, and others and was originally filed in Pennsylvania state court. [read post]
10 Aug 2011, 4:30 am
”: a note on Neurim (The SPC blog) France: The end of the reform on the appearance of generic drugs and IPR (Class 46) Spain: A SHED OF LIGHT IN THE DARK: First Spanish decision admitting post-grant claim limitations under article 138.3 of CPE 2000: Sanofi-Aventis v. [read post]
20 Apr 2015, 4:30 am
Apotex case Monday, case summary and webcast to listen http://t.co/f1KeAesP3r -> [read post]
23 Jun 2010, 10:28 pm
Apotex, Inc. et al. [read post]
19 Oct 2011, 3:30 am
: Daiichi Sankyo Company Limited, Sanofi-Aventis Deutschland GmbH v DEMO Anonimos Viomikhaniki kai Emporiki Etairia Farmakon (IPKat) (The SPC Blog) Naprelan (Naproxen) – US: Lawsuit seeks to compel FDA compliance with PDUFA user fee waiver provisions: Stat-Trade v USFDA (FDA Law Blog) OxyContin(Oxycodone) – US: Purdue Pharma files patent infringement complaint against Ranbaxy in response to Para IV certification filing (Patent Docs) Plavix… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
6 Oct 2010, 4:22 am
Highlights this week included: Prezista (Darunavir) – US NIH becomes first patent holder to join UNITAID Medicines Patent Pool (IP Watch) (KEI) Taxotere (Docetaxel) – US: District Court finds Sanofi’s Taxotere invalid: Aventis v Hospira (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be… [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al… [read post]
22 Jul 2009, 6:05 am
Mylan Inc (Global IP Watch) Lexapro (Escitalopram) – US: Forest and Sun settle Lexapro patent suit (Patent Docs) Lovenox (Enoxaparin) – US: Judge denies attorney fees to Sandoz in patent infringement dispute with Sanofi-Aventis (Patent Docs) Norflox-TZ (Norfloxacin) and Aerocort (Salbutamol) – India: Cipla attracts NPPA’s attention again – alleged overpricing of Salbutamol and Norfloxacin (Spicy IP) Ovide (Malathion) – US:… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
2 Nov 2009, 1:24 pm
At the Wall Street Journal, Dow Jones Newswire’s Kristina Peterson addresses the Court’s denial of cert. in a drug-patent dispute between generic drug manufacturer Apotex Corp. and patent-holders Sanofi-Aventis and Bristol-Myers Squibb, while the Associated Press has coverage of the Court’s decision not to hear an appeal to stop the release of documents relating to sexual abuse lawsuits against Roman Catholic priests in… [read post]
18 Jul 2011, 8:21 am
Lupin, Sanofi v. [read post]
18 Jul 2011, 8:21 am
Lupin, Sanofi v. [read post]
2 Feb 2011, 3:52 am
: (Perhaps) only congress knows for sure (Patent Docs) US: More on data exclusivity (Patent Docs) US: BIO supports Patent Reform Act of 2011 (PatentlyBIOtech) US: President Obama proposes, BIO agrees (Patent Docs) US: Amicus briefs in AMP v USPTO: AARP (Patent Docs) US: Orphan drug designations and applications took off in 2010 while orphan drug approvals tapered off (FDA Law Blog) US: Dexcom wins major reexamination victories over Abbott (Reexamination Alert) Products Actonel (risedronate)… [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and… [read post]
25 Aug 2010, 12:37 am
Apotex Corp. et al. [read post]
21 Jun 2016, 4:00 am
Absent more definitive consistent instruction from the Federal Court of Appeal, or direct SCC pronouncement on the proper approach, patent drafters are still advised to keep their promises to a minimum to avoid disclosure challenges regarding sound prediction. _________________________ [1] Eli Lilly v Hospira 2016 FC 47 (Barnes) [2] Gilead v Idenix 2015 FC 1156 at para 381 (Annis), under appeal A-483-15, adopting earlier reasoning of Astra v Apotex 2014 FC 638… [read post]
19 Jan 2011, 2:00 am
– Health Care Reform Bill (Patent Baristas) US: Academic study supports longer data exclusivity term for conventional drugs (Patent Docs) US: PTO sued after denying ‘mildly tardy’ second interim PTE request: Genetics & IVF Institute v Kappos (FDA Law Blog) US: AMP v USPTO – Appellees’ brief (Patent Docs) Products Avodart (Dutasteride) – US: GlaxoSmithKline file patent infringement complaint against Anchen following Para IV certification… [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
16 Mar 2011, 3:50 am
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium and France… [read post]
